Qstent - Introduction of a simple and yet novel concept against heart attacks in the coronary stent market to the benefit of patients and healthcare payers.

• Research unit: INNOSUISSE
• Project number: 13731.1;6 PFFLM-LS

Short description (German)

Qstent - Introduction of a simple and yet novel concept against heart attacks in the coronary stent market to the benefit of patients and healthcare payers.

Short description (English)

Qstent - Introduction of a simple and yet novel concept against heart attacks in the coronary stent market to the benefit of patients and healthcare payers.

Abstract (German)

The Qstent, a small metal mesh tube, being implanted into coronary arteries to prevent heart attacks, combines the current advantages of drug-eluting stents (reduced re-narrowing risk) with those of bare metal stents (fast ingrowth; hence reduced thrombosis risk). It therefore shows clear clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti coagulant drug therapies and cumbersome re-interventions.

Abstract (English)

The Qstent, a small metal mesh tube, being implanted into coronary arteries to prevent heart attacks, combines the current advantages of drug-eluting stents (reduced re-narrowing risk) with those of bare metal stents (fast ingrowth; hence reduced thrombosis risk). It therefore shows clear clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti coagulant drug therapies and cumbersome re-interventions.